KENILWORTH, N.J.–(BUSINESS WIRE) October 15, 2020 — Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced
Continue reading »
An erectile dysfunction drug left men with 'intensely blue' vision and red-green blindness
A hospital in Turkey has treated 17 men in two years who took double the recommended dose of erectile dysfunction
Continue reading »
First investigational drug therapy for liver disease NASH awaiting FDA approval
Patients with nonalcoholic steatohepatitis (NASH), a chronic liver disease and a leading cause for liver transplantation in the U.S., currently
Continue reading »
FDA wants stronger warning on breast implants about risks
U.S. health officials want women getting breast implants to receive stronger warnings and more details about the possible risks and
Continue reading »
Vaping Could Cause Addiction 'Epidemic' Among Teens, Warns FDA
A new ad campaign, part of the FDA’s anti-tobacco initiative, warns that teenagers who vape are more likely to start
Continue reading »
FDA approves first noninjection glucagon therapy
(HealthDay)—The U.S. Food and Drug Administration has approved the first noninjection glucagon therapy for emergency treatment of severe hypoglycemia, the
Continue reading »
FDA designates molecular test for concussions as ‘breakthrough device’
A portable test to help people suspected of having concussions or mild traumatic brain injuries has received a boost from
Continue reading »
Sunscreen Chemicals Can Seep Into Your Bloodstream, FDA Says
It’s that time of year when doctors remind everyone to layer on the sunscreen. But a new study conducted by
Continue reading »
FDA Approves Duobrii
LAVAL, Quebec, April 25, 2019 /PRNewswire/ — Bausch Health Companies Inc. (NYSE/TSX: BHC) and its dermatology business, Ortho Dermatologics, one
Continue reading »
FDA Approves Skyrizi
NORTH CHICAGO, Ill., April 23, 2019 /PRNewswire/ — AbbVie today announced that the U.S. Food and Drug Administration (FDA) approved
Continue reading »